QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.

JO Jr, Reusing; F, Agena; CN, Kotton; G, Campana; LC, Pierrotti; E, David-Neto

doi:10.1097/tp.0000000000004870

Public

QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.

Shared by NobleBlocks on Nov 22, 2023 • 12:00 AM UTC

Authors:

Reusing JO Jr

Agena F

Kotton CN

Abstract

<h4>Background</h4>Prevention of cytomegalovirus (CMV) infection after kidney transplantation is costly and burdensome.<h4>Methods</h4>Given its promising utility in risk stratification, we evaluated the use of QuantiFERON-CMV (QFCMV) and additional clinical variables in this prospective cohort stud...

Discussions